Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye
- Status
- UNKNOWN
- Phase
- PHASE2
Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
ABT-888 and Temozolomide for Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)
- Status
- TERMINATED
- Phase
- PHASE2
Vitamin D for Treatment of Glioblastoma Multiforme
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Bevacizumab in Recurrent Grade II and III Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
- Status
- COMPLETED
- Phase
- PHASE2
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Veliparib and Temozolomide in Treating Patients With Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion
- Status
- COMPLETED
- Phase
- PHASE1
High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Ipilimumab + Temozolomide in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bevacizumab and Extended Treatment of Temozolomide in Patients With Recurrent Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2